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Abstract
Purpose: This study aimed to analyze the immunohistochemical effect of platelet-rich plasma (PRP) on healing of long-
bone fractures in terms of bone morphogenetic protein-2 (BMP-2), vascular endothelial growth factor (VEGF), the Ki-67
proliferation index, and radiological and histological analyses. Methods: Sixteen adult rabbits, whose right femoral dia-
physis was fractured and fixed with Kirschner wires, were randomly divided into two groups, control and PRP (groups A
and B, respectively). PRP was given to group B at 1 week postoperatively, and all animals were euthanized after 12 weeks.
Radiographic evaluations were performed periodically. Cortical callus formation, chondroid and woven bone area per-
centages, osteoblastic and fibroblastic activities, and mature bone formation were examined. The depths of BMP-2 and
VEGF staining were measured. The Ki-67 proliferation index was also calculated. Results: The mean radiological union
score of group B was significantly higher than that of group A. There were also statistically significant differences between
groups A and B in terms of cortical callus formation, woven bone area percentage, fibroblast proliferation, and mature
bone formation. Group B had significantly more cortical callus and mature bone formation with less woven bone and
fibroblast proliferation. Immunohistochemical analysis revealed no statistically significant difference between the groups in
terms of BMP-2 and VEGF staining and the Ki-67 index.Conclusions: PRP had no effect on BMP-2 or VEGF levels with no
increase in the Ki-67 proliferation index, although its application had a positive effect on bone healing by increasing callus
and mature bone formation with decreased woven bone and fibroblast proliferation.
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Introduction
Bone healing is still a major orthopedic problem, despite
improvements in both biological and biomechanical treat-
ment modalities.1 It has been reported that up to 10% of all
fractures either fail to heal or demonstrate a delay in heal-
ing. This failure of healing increases health-care costs with
prolonged hospital stays, multiple surgeries, and associated
complications. Therefore, in clinical practice, it is crucial to
understand the fundamentals of bone repair processes and
to prevent nonunion or delayed union.
1Department of Orthopaedics and Traumatology, Faculty of Medicine,
Kırıkkale University, Kırıkkale, Turkey
2Department of Orthopaedics and Traumatology, Faculty of Medicine,
Baskent University, Ankara, Turkey
3Department of Pathology, Faculty of Medicine, Baskent University,
Ankara, Turkey
Corresponding author:
Orcun Sahin, Department of Orthopaedics and Traumatology, Faculty of
Medicine, Baskent University, M. Fevzi C¸akmak Cd. 10. Sk. No:40
Bahc¸elievler, 06490 Ankara, Turkey.
Email: drorcunsahin@gmail.com
Journal of Orthopaedic Surgery
26(3) 1–10
ª The Author(s) 2018
Article reuse guidelines:
sagepub.com/journals-permissions
DOI: 10.1177/2309499018802491
journals.sagepub.com/home/osj
Journal ofOr thopaedic
Surger y
Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons
Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial
use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open
Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
There have been numerous clinical and experimental
reports with regard to bone repair processes, and autolo-
gous bone grafting as adjuncts combined with surgical
techniques is widely accepted as the gold standard tech-
nique for the treatment of nonunion or delayed union.2
The application of platelet-rich plasma (PRP) is currently
one of the most popular approaches for treatment of patho-
logies in cartilage, tendons, and bone. PRP is an autologous
concentrate of platelets obtained directly from peripheral
venous blood of the patient, which is produced by the
centrifugation of whole blood.3 Studies have shown that
platelets carry alpha granules that contain growth factors,
angiogenetic factors, and pro-inflammatory cytokines.
They also bear fibrin for induction of angiogenesis.4
Platelets play a significant role in bone healing by promoting
early inflammation and repair stages of the process.5,6
Nevertheless, there is very scarce and inconclusive data
about the exact physiological effect of PRP on bone healing.
To understand this effect, more histological and immuno-
histochemical studies should be performed and comparative
data must be obtained for definitive conclusions. This is one
of the first studies that analyze the in-depth immuno-
histochemical effect of PRP on “acute bone healing” with
histological and radiological outcomes.
Hence, the purpose of this study was to analyze the
effect of PRP on “acute bone healing” process in long-
bone fractures through radiological, histopathological, and
immunohistochemical evaluations of bone morphogenic
protein-2 (BMP-2) for new bone formation, vascular
endothelial growth factor (VEGF) for angiogenesis, and
Ki-67 protein for cell proliferation and to compare the out-
comes with a control group.
Materials and methods
Study groups
This study employed 16 New Zealand-type adult rabbits
(age: 1.5–2 years; weight: 2.5–3.2 kg) and was approved
by the Institutional Ethics Committee in accordance with
the Guide for the Care and Use of the Laboratory Animals
principles (approval number: D13/27). The rabbits were
randomly divided into two groups after their right femoral
diaphysis was fractured and fixed with Kirschner (K) wires:
1. Group A (n ¼ 8) as the control in which rabbits did
not receive any adjuvant treatment for bone healing.
2. Group B (n ¼ 8) was injected with PRP into the
fracture site of the right femur.
After surgery, six rabbits from each group recovered
without any postoperative signs of infection, wound com-
plications, or other systemic problems. The remaining two
rabbits from each group were omitted because of wound
complications causing systemic septicemia. Hence, a total
of 12 rats (6 rabbits in each group) were analyzed for the
final evaluation. All animals were euthanized after 12
weeks of follow-up by an overdose of sodium pentobarbi-
tal. Immediately after euthanizing, the right femur from
each animal was placed in cold 70% ethanol and processed
for histological evaluation.
Surgical procedure and PRP application
After proper cleaning and sterilization of the surgical area, a
3-cm lateral longitudinal incision was made on the right
femoral diaphysis of the rabbits under dissociative anesthesia
induced by 50 mg/kg ketamine and 7 mg/kg xylazine. After
mid-shaft exposure of the femoral bone, an oblique fracture
line was created in the diaphysis by multi-drilling and an
osteotome. Oblique fracture line was preferred for an easier
reduction and fixation with a K-wire and to make the area of
histopathological examination more prominent via a long
fracture line. Then, the fracture was fixed with an intra-
medullary 2.0-mm K-wire entering through the trochanter
major to the intercondylar notch. The rabbits were kept in
clean cages postoperatively, and antibiotic prophylaxis was
applied by intramuscular injections of 50 mg/kg ampicillin
twice a day for 5 days.
To analyze the effect of PRP on “acute bone healing
process”, at 1 week postoperatively, 1 ml of autologous
PRP gel prepared from 5 ml of venous autologous blood
was injected percutaneously into the fracture line under
fluoroscopy guidance in all rabbits of group B. Then, 5
ml of blood was collected from central veins of the ear into
tubes containing 3.8% sodium citrate.7 PRP was obtained
from the anticoagulated blood by the double centrifugation
technique as described previously.7 First, centrifugation
was performed at 150 g for 20 min. At the second stage,
the supernatant obtained from the first centrifugation was
recentrifuged at 450 g for 10 min. The PRP at the bottom of
tubes was then aspirated. Platelet counts before and after
the procedure were performed automatically using a hema-
tology analyzer (Advia 120, Bayer B.V., Mijdrecht, the
Netherlands). The platelet counts prior to PRP preparation
were 9.6–15.4  104 cells. After preparation of PRP, the
platelet counts were increased to 22.9–48  104 cells. PRP
was used as a PRP gel for the experiment. Therefore, before
injection of PRP at the fracture site, the aspirates were
mixed with 10% calcium chloride at a ratio of 1:0.15 and
100 U/ml bovine thrombin for activation of the cells at the
time of injection.
Radiographic evaluation
Radiographic evaluations [anteroposterior(AP) and lateral
plain X-ray of the femur] were performed following the
surgical procedure at week 0 (immediately after surgery),
week 4 (3 weeks after PRP application), week 8, and week
12 (at euthanization). All plain X-rays (65 kVp, 7.5 mA,
and 0.25 s) were evaluated by a blinded observer experi-
enced in musculoskeletal trauma. Digital radiographs of all
animals were downloaded to the picture archiving and
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communication system and evaluated with a scoring sys-
tem including the most commonly used criteria of radio-
graphic bone healing (Table 1).8 In this scoring system,
union was scored according to cortical bridging in AP and
lateral plain radiographs and fracture line visualization
with a maximum score of 0 (no cortical bridging) and a
maximum score of 3 (no fracture visualization). Data
obtained by analysis according to the radiological criteria
at week 12 were then analyzed statistically.
Histopathological analysis
After euthanization, all right femurs were resected 1 cm
proximal and 1 cm distal to the fracture line and sent for
histopathological examination. Femoral bone samples were
fixed in 10% formaldehyde and transferred to 20% formic
acid for decalcification.9 The specimens were embedded in
paraffin, and sections of 5 mm thickness were prepared on
slides. After deparaffinization, the sections were stained
with hematoxylin and eosin. Cortical callus formation,
chondroid and woven bone area percentages, osteoblastic
and fibroblastic activities, and mature bone formation were
examined for histopathological evaluation under a light
microscope at 10 magnification.
Chondroid and woven bone area percentages were mea-
sured using a grid system that divided the section into equal
areas. Cortical callus formation was graded by the grading
system shown in Table 2. Osteoblastic activity was scored
according to the evaluation criteria shown in Table 3.
Fibroblasts within the best representative area of callus
formation at 10 magnification were counted and graded
as 0–50 ¼ 1, 50–100 ¼ 2, and >100 ¼ 3. Mature bone
formation was evaluated as none (grade 0) and present
(grade 1).
Immunohistochemical analysis
For immunohistochemical analysis of growth factor and
cytokine concentrations at the fracture site, the depths of
anti-BMP-2 (monoclonal antihuman Pro-BMP-2 antibody,
(MAB2260, R & D Systems, Inc., Minneapolis, Minnesota,
USA) and VEGF (AB-293-NA, R & D Systems, Inc.) anti-
body staining were measured.10 They were graded immu-
nohistochemically as none (0), mild (1), moderate (2), and
strong (3) staining according to the depth of staining. The
Ki-67 proliferation index was also calculated by counting
cells showing nuclear positivity within 100 proliferative
chondrocytes and osteoblasts in the area of most intense
bone healing.11 Immunohistochemical staining for evalua-
tion of the Ki-67 proliferation index as well as BMP-2 and
VEGF was performed according to a standard protocol.12,13
Positivity of immunostaining was assessed as follows: neg-
ative to 0 (0–5% positive cells), 1 (5–20% positive cells), 2
(20–50% positive cells), and 3 (50–100% positive cells).
Immuno-stained cells were evaluated using a light micro-
scope (Eclipse E400 light microscope; Nikon, Tokyo,
Japan).
Statistical analysis
All data were analyzed with SPSS 17.0 statistical software
(SSPS Inc., Chicago, Illinois, USA). Conformity of the
data to a normal distribution was evaluated by the Sha-
piro–Wilk test. Homogeneity of variances was analyzed
by the Levene’s test. Mean vascular proliferation vari-
ables, which met the assumptions of the parametric tests,
were compared between two independent groups by the
Student’s t-test. When the assumptions of the parametric
tests were not met with respect to the other variables, a
comparison of the median of two independent groups was
made by the Mann–Whitney U test. Data are shown as the
mean + standard deviation, median, minimum and max-
imum values, and interquartile range. In terms of mature
bone formation, the groups were compared by the paired
ratio test. A value of p < 0.05 was considered as statisti-
cally significant.
Results
There were no intraoperative complications during the sur-
gical procedure. Following the PRP injections, no early or
late complications including systemic or local side effects
were observed during the follow-up period.
Table 1. Radiological union score.8
No cortical bridging 0
Cortical bridging only on one radiograph (AP or lateral) 1
Cortical bridging on both radiographs 2
Fracture line not visualized 3
AP: anteroposterior.
Table 2. Histopathological grading of callus formation.
Grade 0 No callus formation
Grade 1 Callus formation in at least one cortex with no
continuation
Grade 2 Callus formation in at least one cortex with
continuation
Grade 3 Callus formation in both cortices
Table 3. Histological evaluation of osteoblastic activity.
Grade 0 No osteoblasts were seen in the magnification area
Grade 1 Osteoblasts were seen only by detailed examination of
the cells in the magnification area
Grade 2 Osteoblasts were easily seen even in small
magnifications
Grade 3 Osteoblasts form clusters
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Radiological evaluation
The mean radiological union scores of groups A and B
were 1.2 (range: 0–3) and 2.7 (range: 2–3), respectively.
Control radiographs at weeks 4, 8, and 12 showed delayed
union of the fracture with less callus formation in group A
compared with group B. Delayed union described as delay
in bone bridging when compared to an adequate control
group.14 However, fracture union with callus formation
was achieved in all rabbits of group B (Figures 1 and 2).
In contrast, radiological nonunion was determined in two
rabbits of group A. The findings obtained according to the
radiological evaluation are summarized in Table 4. Based
on the radiological union scores, the mean score of group B
was significantly higher than that of group A (p < 0.01).
Histological evaluation
Histological results and statistical comparisons between the
groups are summarized in Tables 4 and 5, respectively.
There were statistically significant differences between
groups A and B in terms of cortical callus formation, woven
bone area percentage, fibroblast proliferation, and mature
bone formation (p < 0.01). Conversely, there was no signif-
icant difference in the chondroid area percentage or osteo-
blastic proliferation (p ¼ 0.154 and p ¼ 0.336, respectively)
Although histological analysis revealed that cortical cal-
lus formation was irregular in group A, it was more regu-
larly oriented in group B (Figure 3). Additionally, group A
had more extensive new woven bone formation in the intra-
medullary area compared with group B that had signifi-
cantly more mature bone formation (p < 0.01). Fibroblast
proliferation was also intensified within the granulation
tissue of group A (Figure 3). At 4 magnification,
fibroblast-rich areas were easier to be determined, and there
were a greater number of fibroblasts in group A. In con-
trast, fibroblast-rich areas in group B were more difficult to
identify because they were significantly fewer in number.
Figure 1. AP and lateral radiographs of group A at week 4 (a),
week 8 (b), and week 12 (c) after surgery. AP: anteroposterior. Figure 2. AP and lateral radiographs of group B at week 4 (a),
week 8 (b), and week 12 (c) after surgery. The callus formation
was more prominent in group B. AP: anteroposterior.
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Immunohistochemical evaluation
Mean values of the groups and statistical comparisons of
the immunohistochemical results are shown in Table 6.
There was no statistically significant difference between
the groups in terms of BMP-2 and VEGF staining (p ¼
0.999 and p ¼ 0.471, respectively). At 10 magnification
under a light microscope, the depths of BMP-2 and VEGF
staining were similar in both groups as shown in Figure 4.
Similar results with no statistically significant difference
(p¼ 0.197) in Ki-67 staining was also found in both groups
(Figure 4).
Discussion
This is one of the first studies that has specifically analyzed
the immunohistochemical effect of PRP on long-bone heal-
ing. Although the literature includes numerous clinical and
experimental studies about PRP application and its positive
histological effect on long-bone healing with increased cell
proliferation of osteoblasts and fibroblasts with more callus
formation, the exact immunohistochemical mechanism of
action is still a matter of discussion. Hence, in the current
study, the specific effects of PRP on long-bone healing in
terms of BMP-2 and VEGF together with the Ki-67
Table 4. Radiological and histological results of the study groups.
Group
Callus formation
grade
Chondroid
area
Woven bone
area
Osteoblastic
activity grade
Fibroblast
proliferation
Mature bone
formation
Radiological union
score
A 1 5% 55% 1 3 0 0
A 1 1% 60% 3 2 0 0
A 2 3% 45% 2 3 1 1
A 2 3% 45% 2 3 1 2
A 1 3% 40% 2 3 0 3
A 1 3% 60% 2 2 0 1
B 3 10% 30% 2 1 1 2
B 3 1% 25% 2 1 1 2
B 3 <1% 30% 3 1 1 3
B 3 <1% 30% 3 2 1 3
B 3 <1% 15% 2 1 1 3
B 3 3% 30% 2 1 1 3
Table 5. Mean values and statistical comparison results of the
histological parameters.
Histological parameters
Group A
(mean + SD)
Group B
(mean + SD)
p
Value
Cortical callus form. 1.33 + 0.52 3 + 0.0 <0.01a
Chondroid area 3 + 1.26 2.3 + 3.93 0.154
Woven bone area 50.83 + 8.61 26.67 + 6.05 <0.01a
Osteoblast prolif. 2 + 0.63 2.33 + 0.52 0.336
Fibroblast prolif. 2.67 + 0.52 1.17 + 0.41 <0.01a
Mature bone form. 0.33 + 0.13 1 + 0.0 <0.01a
SD: standard deviation, form: formation, prolif: proliferation.
aStatistically significant results.
Figure 3. Fracture samples with H & E staining under light
microscopy at 10 magnification. (a) Group A and (b) group B. (I)
The callus formation was more prominent in group B. (II) More
vascular proliferation was detected in group B. (III) Fibroblast
proliferation in group A was more prominent than in group B. H &
E: hematoxylin and eosin.
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Table 6. Immunohistochemical outcomes of the study groups with statistical comparison results.
Immunohistochemical parameters Group A (mean + SD (min–max)) Group B (mean + SD (min–max)) p Value
BMP-2 1.67+ 0.46 (1–3) 1.41+ 0.82 (0–3) 0.999
VEGF 2.43+ 1.36 (0–3) 2.32+ 1.93 (0–3) 0.471
Ki-67 PI 1.83+ 2.61 (0–3) 1.92+ 6.05 (1–3) 0.197
SD: standard deviation; BMP-2: bone morphogenetic protein-2; PI: proliferation index; VEGF: vascular endothelial growth factor.
Figure 4. Immunohistochemical analysis of the right femoral bone samples at 10 magnification under light microscopy. (a) Group A
and (b) group B. The depths of (I) BMP-2 and (II) VEGF staining and (III) Ki-67 nuclear positivity are provided. There were no significant
differences between the groups for all staining. BMP-2: bone morphogenetic protein-2; VEGF: vascular endothelial growth factor.
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proliferation index were analyzed to understand the path-
ways of PRP in long-bone healing.
In the last decade, PRP application has gained broad
popularity in orthopedics with various studies analyzing
the role of high concentrations of platelets in histological,
mechanical, and clinical aspects of fracture healing. The
most commonly accepted scientific data about the effec-
tiveness of PRP is the release of high concentrations of
various platelet-derived biological agents including
platelet-derived growth factor (PDGF), transforming
growth factor beta, and interleukin 1.3,12–15 It is generally
accepted that these bioactive agents play a considerable
role in inflammation, neovascularization with vascular
remodeling, differentiation of mesenchymal cells, and
synthesis and remodeling of both bone and cartilage tis-
sues.16 Nevertheless, the exact physiological pathways of
this considerable role of PRP is still a matter of discussion.
Hence, in our study, we determined whether PRP had any
effect on bone repair with regard to the immunohistochem-
ical mechanism of action including BMP-2 and VEGF pro-
duction and the Ki-67 proliferative index.
Although numerous benefits ascribed to PRP and the
promising results reported for its therapeutic potential, the
clinical outcomes are heterogeneous and sometimes contra-
dictory due to both the application of different protocols
and the lack of standardization in PRP preparation proce-
dures. This has led to incomparable results and inconclu-
sive data about the real efficacy of PRP. Among the several
variables affecting PRP efficacy, platelet activation is a
crucial step that might influence the availability of bioac-
tive molecules.11,12 Currently, there is lack of evidence on
the most suitable method for PRP activation, and the choice
of strategy for activation is mainly based on practical rea-
sons rather than supported by studies. Although different
activation steps before PRP administration are analyzed in
various studies, the most commonly used method is the
addition of thrombin and/or calcium chloride (CaCl2). In
a study by Cavallo et al., different activation methods for
PRP were compared with regard to the release of growth
factors and as a conclusion it was stated that CaCl2 induced
a progressive release of growth factors increasing up to
24 h.17 We believe that, activation of PRP is the most critical
step for the effectiveness of PRP application. Therefore, in
our study, all PRPs were activated with both thrombin and
CaCl2 to increase the efficacy of PRP. Nevertheless, as a
limitation of our study, a separate study group that only
includes thrombin and CaCl2 should be analyzed in future
studies to better understand the effect of PRP.
In the literature, the incidence of traumatic nonunion of
femur is approximately 2–8%.17 To overcome this almost
highly common complication, different efforts have been
described in the literature so far, including the PRP appli-
cation. In a prospective clinical study, Malhotra et al. ana-
lyzed 30 femoral nonunions treated with PRP application
and only 5 of them accepted as failure after 4 months of
follow-up.18 So, the authors concluded that PRP is a safe
and effective treatment for the treatment of long-bone non-
union. In a recent meta-analysis by Gianakos et al., 29
different articles from the literature were analyzed, and
89% of the studies reported significant improvement in
earlier bone healing after PRP application.19 In our study,
fracture union with callus formation was achieved in all
rabbits in group B (PRP group), whereas two nonunions
were detected in the control group. So, we believe that PRP
has a positive effect on acute fracture healing. In the current
study, we just analyze the effect of PRP on acute bone
healing. Future studies are needed comparing PRP with
autologous bone grafting for the treatment of long-bone
nonunions or delayed unions.
Although there were numerous clinical and biomecha-
nical studies analyzing the femoral nonunions in
humans, there are very few clinically useful reports that
describe femoral fracture repair and prognosis in
rabbits.9,11,20 Although different fracture fixation tech-
niques have been advocated for rabbit femurs, these tech-
niques are usually in the context of an experimental
procedure rather than treatment of the fracture. Addition-
ally, the conformation of the rear limbs and their excessive
muscle mass complicates immobilization process in these
animals.12,20 It is also stated in the literature that low-bone
density and large muscle mass of rabbits may predispose
frequent fractures and/or non-unions. In the current study,
there were two nonunions in group A. We believe that,
apart from the specific features of the rabbits, insufficient
fixation and immobilization may lead to these nonunions.
Histological effect of PRP on bone healing
Previous studies clearly show that exogenous application of
thrombocyte-related growth factors induces proliferation of
osteoblasts in cell culture.6 In animal studies, increased
osteoblastic proliferation and activity are also found with
induction of various thrombocyte-related growth fac-
tors.7,21 These studies emphasize that increases in differ-
entiation, proliferation, and metabolic activity of
osteoblasts is strongly related to PDGF and other proteins
secreted from platelets, leading to the activation of intra-
cellular signaling pathways for matrix synthesis and cellu-
lar differentiation.22 Our study does not have comparable
results with the literature. In our study, we found no sig-
nificant difference in osteoblastic proliferation after PRP
injection. We believe that PRP has a major effect on the
early inflammatory phase of fracture healing, including the
formation of a fracture hematoma and proliferation of
mesenchymal stem cells derived from the bone marrow,
without any direct effect on osteoblastic differentiation.
Callus formation with lamellar (mature) bone is one of
the most critical points for fracture union. All studies about
this issue specifically focus on this aspect to determine the
quality of fracture union. Almost all studies of PRP appli-
cation for bone healing emphasize the positive effect of
PRP on callus formation. However, there are controversial
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results in the literature about the formation of woven versus
lamellar bone after PRP application. In a study by Simman
et al., a significantly increased amount of callus formation
was detected in healing bone after PRP application.23 It has
also been reported that significantly less woven bone and a
higher rate of lamellar bone are seen in the fracture zone
after PRP treatment. In contrast, Sarkar et al. found no
histologically or histochemically significant differences
between PRP treatment and the control in terms of woven
and lamellar bone formation.24 For callus formation, we
obtained comparable results with the literature. In the cur-
rent study, callus formation in the PRP group was more
evident and extensive compared with the control group.
Additionally, there was more woven bone histologically
in the control group compared with the PRP group that had
more advanced lamellar bone formation in the fracture
zone. Therefore, we believe that PRP has a direct positive
effect on callus and lamellar bone formation.
It is very well documented that fibroblastic invasion of
the fracture zone, which is seen in the early stages of bone
healing, is replaced by osteoblasts and chondroblasts at
later stages.23 This cellular differentiation is one of the
major steps of bone healing, which leads to endochondral
new bone formation. Although fibroblastic proliferation
after PRP application has not been analyzed frequently, our
study has comparable results with the literature. The PRP
group had a lower number of fibroblasts compared with the
control group in the current study, demonstrating a more
advanced stage of fracture healing in the PRP group.23
Immunohistochemical effect of PRP on bone healing
The literature contains various studies analyzing different
biochemical markers that promote bone healing. Among
these, BMPs and VEGF are the most commonly used
markers which induce angiogenesis and bone forma-
tion.25,26 In a review article by Barrena et al., it was
clearly stated that neovascularization of fracture zone is
crucial for successful bone healing, providing oxygen and
delivering progenitor cells, and BMPs and VEGF are key
osteogenic and angiogenic factors in this process.25 Ki-67
proliferation index is also one of the most commonly used
markers that specifically demonstrates cellular prolifera-
tion. In a study by Scholzen et al., it was stated that the
monoclonal antibodies that react with the Ki-67 equiva-
lent protein from rodents extends the use of the Ki-67
protein as a proliferation marker to laboratory animals that
are routinely used in basic research.27 Hence, in our study,
we preferred to use BMP, VEGF, and Ki-67 index for the
immunohistochemical analysis.
One of the bioactive agents detected at the fracture site
after PRP injection is BMP-2. BMP-2 is a signaling mole-
cule that influences cell division, matrix synthesis, and
tissue differentiation by recruiting mesenchymal stem cells
from the surrounding muscle, bone marrow, and blood
vessels and by differentiating these cells into osteoblasts
to form either bone directly or cartilage cells that subse-
quently differentiate into bone cells. The literature has
inconclusive data about the effect of BMP-2 on bone
healing. In a meta-analysis by Garrison et al., in 2010,
11 randomized controlled trials of BMP treatment for frac-
ture healing in skeletally mature adults were analyzed. In
conclusion, it was stated that there is limited evidence for
the use of BMP-2 for bone healing.28 Additionally,
although there have been various studies and systematic
reviews about BMP usage in bone healing, there is no
single article that specifically reports the interaction
between PRP and BMP. In our study, we evaluated
BMP-2 staining at week 12 for comparison with the con-
trol group. There was no significant difference in BMP
staining between the groups. The reason for this result
may be the timing of the analysis. BMP-2 expression
increases and reaches plateau at the second week of nor-
mal fracture healing and subsequently decreases for 2–4
weeks until the initiation of ossification. Nevertheless, in
the current study, BMP-2 staining was analyzed after 12
weeks. The characteristic changes in BMP-2 concentra-
tions may explain why we did not observe different BMP-
2 levels between the two groups.
VEGF is a potent angiogenic factor that was first
described as an essential growth factor for vascular
endothelial cells. Although its detailed effects on bone
metabolism remain unclear, it is believed to have a major
role in extracellular matrix remodeling, angiogenesis, and
bone formation. In the literature, there have been numer-
ous studies of PRP and its VEGF content. In a review
article by Alsousou et al., it was clearly stated that VEGF
is an important signaling molecule in PRP, which stimu-
lates angiogenesis and cell migration.29 Nevertheless, to
our knowledge, there is no study that has specifically
analyzed VEGF expression after PRP application for
long-bone healing. In our study, we found no significant
difference in VEGF staining between the groups. The
harvested material was stained for VEGF after 12 weeks
of fracture formation. Therefore, we believe that VEGF
may not have an effect on long-bone healing, especially in
late phases of fracture union.
We concluded that, although PRP application had a pos-
itive effect on bone healing by increasing callus and mature
bone formation with decreased woven bone and fibroblast
proliferation,30,31 it had no effect on BMP-2 or VEGF lev-
els with no increase in the Ki-67 proliferation index. Hence,
the current study demonstrates that PRP does not increase
chondrocyte functions or endochondral ossification with-
out any further increase in osteoblastic functions and angio-
genesis. Additional studies are needed with a larger study
population and different time points for evaluations.
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